Potentiation of ibudilast inhibition of platelet aggregation in the presence of endothelial cells

Thrombosis Research

Volumn 102, Issue 3, 2001, Pages 239-246

  Rile, Ge ^a   Yatomi, Yutaka ^a   Qi, Ruomei ^a   Satoh, Kaneo ^a   Ozaki, Yukio ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Endothelial cells; Ibudilast; Light scattering; Platelet aggregation; Thrombin receptor activating peptide; Whole blood aggregation

Indexed keywords

IBUDILAST; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ARTICLE; BLOOD CELL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION; UMBILICAL VEIN;

BLOOD PLATELETS; COCULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENDOTHELIUM, VASCULAR; HUMANS; KINETICS; PEPTIDE FRAGMENTS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PYRIDINES; UMBILICAL VEINS;

EID: 0035341064     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00258-4     Document Type: Article

References (29)

1. Motwani JG, Topol EJ Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 97:1998;916-931.
2. Goldszmidt A, Wityk RJ Recent advances in stroke therapy. Curr Opin Neurol. 11:1998;57-64.
3. Joseph JE, Machin SJ New antiplatelet drugs. Blood Rev. 11:1997;178-190.
4. Theroux P Antiplatelet therapy: do the new platelet inhibitors add significantly to the clinical benefits of aspirin? Am Heart J. 134:1997;S62-S70.
5. Miller DB Secondary prevention for ischemic heart disease. Relative numbers needed to treat with different therapies. Arch Intern Med. 157:1997;2045-2052.
6. Marcus AJ Thrombosis and inflammation as multicellular processes: significance of cell-cell interactions. Semin Hematol. 31:1994;261-269.
7. Zimmerman GA, McIntyre TM, Prescott SM Adhesion and signaling in vascular cell-cell interactions. J Clin Invest. 98:1996;1699-1702.
8. Moncada S, Gryglewski R, Bunting S, Vane JR An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 263:1976;663-665.
9. Marcus AJ, Weksler BB, Jaffe EA, Broekman MJ Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells. J Clin Invest. 66:1980;979-986.
10. Murata T, Ushikubi F, Matsuoka T, Hirata M, Yamasaki A, Sugimoto Y, Ichikawa A, Aze Y, Tanaka T, Yoshida N, Ueno A, Ohishi S, Narumiya S Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature. 388:1997;678-682.
11. Andersen NH, Eggerman TL, Harker LA, Wilson CH, De B On the multiplicity of platelet prostaglandin receptors: I. Evaluation of competitive antagonism by aggregometry. Prostaglandins. 19:1980;711-735.
12. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Alyonycheva TN, Safier LB, Hajjar KA, Posnett DN, Schoenborn MA, Schooley KA, Gayle RB, Maliszewski CR The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest. 99:1997;1351-1360.
13. Valles J, Santos MT, Aznar J, Marcus AJ, Martinez-Sales V, Portoles M, Broekman MJ, Safier LB Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood. 78:1991;154-162.
14. Ohashi M, Ohkubo H, Kito J, Nishino K A new vasodilator 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine (KC-404) has a dual mechanism of action on platelet aggregation. Arch Int Pharmacodyn Ther. 283:1986;321-334.
15. Hisayama T, Takayanagi I, Goromaru N, Okamoto Y Potentiating effect of 3-isobutyryl-2-isopropylpyrazolo-[1,5a]-pyridine (KC-404), a new cerebral vasodilator with anti-platelet activity, on prostacyclin-induced increase of cyclic AMP content in platelets of rat. Gen Pharmacol. 20:1989;183-186.
16. Fukuyama H, Kimura J, Yamaguchi S, Yamauchi H, Ogawa M, Doi T, Yonekura Y, Konishi J Pharmacological effects of ibudilast on cerebral circulation: a pet study. Neurol Res. 15:1993;169-173.
17. Miura Y, Yatomi Y, Rile G, Ohmori T, Satoh K, Ozaki Y Rho-mediated phosphorylation of focal adhesion kinase and myosin light chain in human endothelial cells stimulated with sphingosine 1-phosphate, a bioactive lysophospholipid released from activated platelets. J Biochem. 127:2000;909-914.
18. Igawa T, Tani T, Chijiwa T, Shiragiku T, Shimidzu S, Kawamura K, Kato S, Unemi F, Kimura Y Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells. Thromb Res. 57:1990;617-623.
19. Born GVR Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 194:1962;927-929.
20. Born GVR Observations on the change in shape of blood platelets brought about by adenosine diphosphate. J Physiol. 209:1970;487-511.
21. Ozaki Y, Satoh K, Yatomi Y, Yamamoto T, Shirasawa Y, Kume S Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem. 218:1994;284-294.
22. Dhall DP, Engeset J, McKenzie FN, Matheson NA Screen filtration pressure of blood - an evaluation. Cardiovasc Res. 3:1969;147-154.
23. Dhall DP, Matheson NA Platelet aggregate filtration pressure - a method of measuring platelet aggregation in whole blood. Cardiovasc Res. 3:1969;155-160.
24. Ozeki Y, Sudo T, Toga K, Nagamura Y, Ito H, Ogawa T, Kimura Y Characterization of whole blood aggregation by a new type aggregometer with screen filtration pressure method. Thromb Res. 2000;. in press.
25. Vu T-KH, Hung DT, Wheaton VI, Coughlin SR Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 64:1991;1057-1068.
26. Ngaiza JR, Jaffe EA A 14 amino acid peptide derived from the amino terminus of the cleaved thrombin receptor elevates intracellular calcium and stimulates prostacyclin production in human endothelial cells. Biochem Biophys Res Commun. 179:1991;1656-1661.
27. Allen GT, Normandin D, Antonaccio MJ Involvement of the "tethered ligand" receptor in thrombin-induced endothelium-mediated relaxations. Am J Physiol. 265:1993;H1744-H1749.
28. 2+, prostacyclin, or permeability. Biochem Pharmacol. 53:1997;487-491.
29. Kishi Y, Ohta S, Kasuya N, Tatsumi M, Sawada M, Sakita S, Ashikaga T, Numano F Ibudilast modulates platelet-endothelium interaction mainly through cyclic GMP-dependent mechanism. J Cardiovasc Pharmacol. 36:2000;65-70.